Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
The conclusions of Simpson and colleagues (Dec. 15 issue)
1
regarding the effectiveness and quality-of-life–enhancing capacity of dupilumab in patients with atopic dermatitis open new perspectives in the strategies of treatment of allergic diseases, because interleukin-4 and interleukin-13 are “type 2 inflammatory cytokines...
Alternative Titles
Full title
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1878826285
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1878826285
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1700366
